Clinical Relevance of GB Virus C & Hepatitis C Virus in HIV+ Women
GB 病毒 C 的临床相关性
基本信息
- 批准号:7884585
- 负责人:
- 金额:$ 19.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-02 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAddressBasic ScienceCD4 Lymphocyte CountClinical ResearchCollaborationsCommunicable DiseasesDataDiagnosisDiseaseDisease ProgressionDrug usageFamilyFlaviviridaeFutureGB virusGB virus CGenderGene MutationGenotypeHCV Liver DiseaseHIVHIV SeropositivityHealthHepatitis C virusHigh PrevalenceHigh Risk WomanIndividualInfectionInjection of therapeutic agentInterferonsKnowledgeLaboratoriesLeadLiteratureLiverLiver diseasesLongitudinal StudiesMeasuresMediatingMorbidity - disease rateOpportunistic InfectionsOutcomeOverdoseParticipantPersonsPopulationPrevalenceProspective StudiesPublicationsRNARNA VirusesReceptor GeneRelative (related person)ReportingResourcesRoleSerologicalSex CharacteristicsSubstance abuse problemTimeTreatment outcomeUniversitiesVascular blood supplyViremiaVirusVirus DiseasesVirus ReplicationWomanWorkabstractingantiretroviral therapyclinically relevantcohortethnic minority populationexperiencehuman diseasein vivoinnovationmalemenmortalitynovel therapeuticspublic health relevanceracial and ethnictreatment strategy
项目摘要
DESCRIPTION (provided by applicant): (GBV-C) is a single-stranded RNA virus that is the closest known relative of hepatitis C virus (HCV). GBV-C has not been associated with any human disease to date. However, several studies have reported a beneficial effect of GBV-C viremia on HIV disease progression - reduced HIV RNA levels, increased CD4 cell counts, and slower disease progression - predominantly in cohorts with a high proportion of men. However, the prevalence of GBV-C differs significantly between men and women, and no large prospective studies have examined the effects of GBV-C co-infection on HIV disease progression in women. In a preliminary study, we found that GBV-C genotype 2 was associated with higher CD4 cell counts compared to genotype 1, and that GBV-C genotype 2 was more sensitive to clearance after interferon treatment than GBV-C genotype 1. Therefore, we propose to evaluate the presence of GBV-C co-infection and the role of GBV-C genotype in modulating HIV disease progression in a well-characterized cohort of women with HIV/AIDS to enhance our knowledge of GBV-C/HIV interactions. This work is significant and innovative because no large prospective studies of the role of GBV-C co-infection in modulating HIV disease have been reported in HIV positive women and because its addresses a potentially beneficial interaction between GBV-C and HIV that could be exploited in the future to develop novel therapeutic strategies. PUBLIC HEALTH RELEVANCE: To date, GB virus type C (GBV-C) has not been associated with any human disease, although several studies have reported a beneficial effect of GBV-C infection on HIV disease progression. The prevalence of GBV-C may differ by gender; however, the adventitious role of GBV-C co-infection on HIV disease, as well as the potential modulatory effects of GBV-C genotype, has not yet been evaluated in a longitudinal manner in women. Such studies could ultimately lead to novel therapeutic strategies to treat HIV disease, particularly among difficult-to-treat populations and/or individuals with limited access to antiretroviral therapy.
描述(申请人提供):(GBV-C)是一种单链RNA病毒,是已知的丙型肝炎病毒(丙型肝炎病毒)的最近亲属。到目前为止,GBV-C还没有与任何人类疾病有关。然而,几项研究报告了GBV-C病毒血症对艾滋病毒疾病进展的有益影响--降低艾滋病毒RNA水平,增加CD4细胞计数,减缓疾病进展--主要是在男性比例较高的队列中。然而,GBV-C的患病率在男性和女性之间存在显著差异,而且还没有大型前瞻性研究检查GBV-C混合感染对女性艾滋病毒疾病进展的影响。在一项初步研究中,我们发现与基因1相比,GBV-C基因2与更高的CD4细胞计数相关,并且GBV-C基因2比基因1对干扰素治疗后的清除更敏感。因此,我们建议评估GBV-C合并感染的存在以及GBV-C基因在调节HIV疾病进展中的作用,以增强我们对GBV-C/HIV相互作用的了解。这项工作具有重大意义和创新性,因为尚未有关于GBV-C合并感染在HIV阳性妇女中调节HIV疾病的作用的大型前瞻性研究报告,而且它解决了GBV-C和HIV之间的潜在有益相互作用,未来可以利用这种相互作用来开发新的治疗策略。公共卫生相关性:到目前为止,GB病毒C型(GBV-C)尚未与任何人类疾病有关,尽管一些研究报告了GBV-C感染对艾滋病毒疾病进展的有益影响。GBV-C的患病率可能因性别不同而不同;然而,GBV-C混合感染对艾滋病毒疾病的外来作用以及GBV-C基因的潜在调节作用尚未在女性中进行纵向评估。这类研究最终可能导致治疗艾滋病毒疾病的新治疗战略,特别是在难以治疗的人群和/或获得抗逆转录病毒治疗机会有限的个人中。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Role of GB virus C in modulating HIV disease.
GB病毒C在调节HIV疾病中的作用。
- DOI:10.1586/eri.12.37
- 发表时间:2012-05
- 期刊:
- 影响因子:5.7
- 作者:Schwarze-Zander C;Blackard JT;Rockstroh JK
- 通讯作者:Rockstroh JK
Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany.
- DOI:10.1002/jmv.22029
- 发表时间:2011-04
- 期刊:
- 影响因子:12.7
- 作者:Neibecker, Markus;Schwarze-Zander, Carolynne;Rockstroh, Juergen K.;Spengler, Ulrich;Blackard, Jason T.
- 通讯作者:Blackard, Jason T.
Cytokine/chemokine expression associated with Human Pegivirus (HPgV) infection in women with HIV.
- DOI:10.1002/jmv.24836
- 发表时间:2017-11
- 期刊:
- 影响因子:12.7
- 作者:Blackard JT;Ma G;Welge JA;Taylor LE;Mayer KH;Klein RS;Celentano DD;Sobel JD;Jamieson DJ;King CC
- 通讯作者:King CC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JASON T BLACKARD其他文献
JASON T BLACKARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JASON T BLACKARD', 18)}}的其他基金
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination
酒精或酒精/合成阿片类药物组合改变 HIV 药物代谢的治疗和机制意义
- 批准号:
10542286 - 财政年份:2022
- 资助金额:
$ 19.43万 - 项目类别:
Therapeutic and mechanistic significance of altered metabolism of HIV medicines by alcohol- or alcohol/synthetic opioid combination
酒精或酒精/合成阿片类药物组合改变 HIV 药物代谢的治疗和机制意义
- 批准号:
10700069 - 财政年份:2022
- 资助金额:
$ 19.43万 - 项目类别:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
BK 多瘤病毒相关出血性膀胱炎的病毒和宿主预测因子
- 批准号:
10203959 - 财政年份:2020
- 资助金额:
$ 19.43万 - 项目类别:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
BK 多瘤病毒相关出血性膀胱炎的病毒和宿主预测因子
- 批准号:
10434701 - 财政年份:2020
- 资助金额:
$ 19.43万 - 项目类别:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
BK 多瘤病毒相关出血性膀胱炎的病毒和宿主预测因子
- 批准号:
10653831 - 财政年份:2020
- 资助金额:
$ 19.43万 - 项目类别:
Viral and host predictors of BK polyomavirus associated hemorrhagic cystitis
BK 多瘤病毒相关出血性膀胱炎的病毒和宿主预测因子
- 批准号:
10029242 - 财政年份:2020
- 资助金额:
$ 19.43万 - 项目类别:
Omics analysis of HIV during synthetic opioid exposure
合成阿片类药物暴露期间 HIV 的组学分析
- 批准号:
10548205 - 财政年份:2019
- 资助金额:
$ 19.43万 - 项目类别:
Omics analysis of HIV during synthetic opioid exposure
合成阿片类药物暴露期间 HIV 的组学分析
- 批准号:
9883771 - 财政年份:2019
- 资助金额:
$ 19.43万 - 项目类别:
Omics analysis of HIV during synthetic opioid exposure
合成阿片类药物暴露期间 HIV 的组学分析
- 批准号:
10158901 - 财政年份:2019
- 资助金额:
$ 19.43万 - 项目类别:
Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV
基因型
- 批准号:
9267990 - 财政年份:2013
- 资助金额:
$ 19.43万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 19.43万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 19.43万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 19.43万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 19.43万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 19.43万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 19.43万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 19.43万 - 项目类别: